ArticleMovement disorders : official journal of the Movement Disorder Society2017

Ceftriaxone reduces L-dopa-induced dyskinesia severity in 6-hydroxydopamine parkinson's disease model.

Tanya Chotibut et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.